Cytomegalovirus infection and colonic perforation in renal transplant patients

Transplant International

Volumn 9, Issue 3, 1996, Pages 248-251

  Toogood, Giles J ^a,c   Gillespie, Patrick H ^a   Gujral, Sandy ^a   Warren, Bryan F ^b   Roake, Justin A ^a   Gray, Derek W R ^a   Morris, Peter J ^a  

^a Oxford Transplant Centre   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

CMV, colonic perforation, kidney transplantation; Colonic perforation, CMV, kidney transplantation; Kidney transplantation, colonic perforation, CMV; Perforation, colon, CMC

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CASE REPORT; COLON PERFORATION; CYTOMEGALOVIRUS INFECTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL INFECTION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INTESTINE RESECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LAPAROTOMY; MALE; MORBIDITY; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PERITONITIS; PRIORITY JOURNAL; SEPSIS;

AGED; ANTIVIRAL AGENTS; COLONIC DISEASES; COLOSTOMY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL PERFORATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0029877109     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00335394     Document Type: Article

References (22)

1. Aylward RG, Karim MA, Chiu A, Landsberg D, Shackleton CR, Keown PA (1991) The role of monoclonal antibody (OKT3), antilymphocyte globulins (ALG), CMV serology as risk factors for the development of cytomegalovirus (CMV) infections following renal transplantation (abstract). J Am Soc Nephrol 2: 791
2. Balfour HH, Chase BA, Stapelton JT. Simmons RL, Fryd DS (1989) A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381-1387
3. Buckner FS, Pomeroy C (1993) Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 17: 644-656
4. Cohen AT, O'Grady JG, Sutherland S (1993) Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J Med Virol 40: 5-9
5. Conti DJ, Freed BM, Lempert N (1993) Prophylactic immunoglobulm therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease. Transplant Proc 25: 1421-1422
6. Conti DJ, Freed BM, Gruber SA, Lempert N (1994) Prophlaxis of primary cytomegalovirus disease in renal transplant recipients. Arch Surg 129:443-447
7. Demling RH, Salvatierra O, Beizer FO (1975) Intestinal necrosis and perforation after renal transplantation. Arch Surg 110: 251-253
8. De Riso AJ, Kemeny MM, Tores RA, Oliver JM (1989) Multiple jejunal perforations secondary to cytomegalovirus in a patient with acquired immune deficiency syndrome. Case report and review. Dig Dis Sci 34: 623-629
9. Goodman ZD, Boitnott JK, Yardley JH (1979) Perforation of the colon associated with cytomegalovirus infection. Dig Dis Sci 24: 376-380
10. Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA (1975) The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 293: 1109-1112
11. Kram HB, Shoemaker WC (1990) Intestinal perforation due to cytomegalovirus in patients with AIDS. Dis Co Ion Rectum 33: 1037-1040
12. McCarthy JM, Karim MA, Krueger H, Keown PA (1993) A cost impact of cytomegalovirus disease in renal transplant recipients. Transplantation 55: 1277-1282
13. Misra MK, Pinkus GS, Birtch AG, Wilson RE (1973) Major colonic diseases complicating renal transplantation. Surgery 73:942-948
14. Rosen P, Armstrong D, Rice N (1973) Gastrointestinal cytomegalovirus infection. Arch Intern Med 132: 274-276
15. Schroeder TJ, First MR (1994) Cytomegalovirus infection and the role of ganciclovir prophylaxis in transplant recipients. J Nephrol 7: 77-88
16. Snydman DR, Werner BG, Heinze-Lacey B (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317: 1049-1054
17. Sutherland DER. Chan FY, Foucar E, Simmons RL, Howard RJ, Najarian JS (1980) The bleeding caecal ulcer in transplant patients. Surgery 86: 386-398
18. Suwansirikul S, Roa N, Dowling JN, Ho M (1977) Primary and secondary cytomegalovirus infection. Clinical manifestations after renal transplantation. Arch Intern Med 137:1026-1029
19. Tatum ET, Sun PC, Cohn DL (1989) Cytomegalovirus vasculitis and colon perforation in a patient with the acquired immune syndrome. Pathology 21: 235-238
20. The TH, Ploeg M van der, Berg AP van den, Vheger AM, Giessen M van der, Son WJ van (1992) Direct detection of cytomegalovirus in peripheral blood leukocytes. A review of the antigenemia assay and polymerase chain reaction-Transplantation 54: 193-198
21. Wexner SD, Smithy WB, Trillo C, Hopkins BS, Dailey TH (1988) Emergency colectomy for cytomegalovirus ileocolitis in patients with acquired immune deficiency syndrome. Dis Colon Rectum 31: 755-761
22. Winston DJ, Wirin D, Shaked A, Busuttil RW (1995) Randomised comparison of ganciclovir and high dose acyclovir for long term cytomegalovirus prophylaxis in liver transplant recipients. Lancet 346: 69-74